Emerson gifts automation tech for simulated bioprocessing in Ireland

By Flora Southey contact

- Last updated on GMT

GettyImages/AlexRaths
GettyImages/AlexRaths
Emerson is donating an automation platform worth $1m to Ireland’s NIBRT for ‘real-life’ industry training in Dublin.

The planned Emerson Room at the National Institute of Bioprocessing Research and Training (NIBRT) – designed to simulate a bioprocessing environment – will house the DeltaV distributed control system.

The platform is used in the digitisation and automation of biologics manufacturing processes and uses facilities remote monitoring and automation control from multiple locations, Emerson Automation Solutions’ Daniel Keogh spokesperson told us.

“It is used from laboratory research and development through full-scale commercial manufacturing to help companies lower costs, reduce time to market, and improve quality.”

The collaboration will help address a key challenge for the industry, said Keogh: “The need to expand the pool of industry ready operators.”

“By providing access to the technology within a state of the art training facility, this will help pharmaceutical companies to upskill the next generation of operators, essential for the industry to more quickly and safely produce quality medicines that improve the lives of patients across the globe.”

First students will train on the platform in Q3, 2018.

Last week NIBRT announced plans​ to expand to North America in partnership with Philadelphia’s Jefferson University, but Keogh said currently, the Missouri-headquartered firm is providing technology to NIBRT’s Dublin site only.

Related news

Show more

Related products

show more

Seasonal Vaccine Manufacturing

Seasonal Vaccine Manufacturing

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

The production of seasonal vaccines, such as those for influenza, presents unique challenges to manufacturers due to the necessary time constraints resulting...

Consideration and Options for Prefilled Syringes

Consideration and Options for Prefilled Syringes

Baxter BioPharma Solutions | 10-Feb-2021 | Technical / White Paper

Convenience, product differentiation, and less waste are great reasons for developing a product in a prefilled syringe. Baxter’s whitepaper describes the...

Rapid Biosafety Testing Enables the Future of Manufacturing

Rapid Biosafety Testing Enables the Future of Manufacturing

Viral Safety for mAb: Prevent, Detect, Remove | 23-Nov-2020 | Technical / White Paper

This white paper explores the factors driving the evolution toward faster biosafety testing and describes rapid approaches for adventitious agent testing...

Related suppliers

Follow us

Products

View more

Webinars